AHS

Matthew Robbins, MD: Headaches Associated With COVID-19

July 21, 2020

The director of the Neurology Residency Program at Weill Cornell Medicine highlighted some of the differences in types of headaches that patients with COVID-19 experience, as well as overall takeaways from the pandemic itself.

Fred Cohen, MD: OnabotulinumtoxinA and CGRP Combination Treatment

July 15, 2020

The internal medicine resident physician at Montefiore Health System provided an overview of the study he and colleagues conducted on patients using onabotulinumtoxinA and CGRP agents in tandem.

Kathleen Digre, MD, on Eye Pain and Photophobia in Migraine

July 14, 2020

Despite its ranking as a "most bothersome symptom" among migraineurs, eye pain and photophobia often go ignored or under-treated in the headache clinic.

Total Migraine Pain Burden Reduced With Galcanezumab in Post-Hoc Analysis

July 13, 2020

Treatment with galcanezumab (Emgality; Eli Lilly) was associated with improvements in total pain burden for patients with both chronic and episodic migraine compared to placebo groups.

Matthew Robbins, MD: Residency During COVID-19

July 09, 2020

The director of the Neurology Residency Program at Weill Cornell Medicine provided insight on the experience residents have had during the COVID-19 pandemic and how it has shaped them for the future.

Chia-Chun Chiang, MD: Collecting Real-World Data Following FDA Approvals

July 07, 2020

The neurologist at Mayo Clinic in Phoenix, Arizona, detailed the importance of further studies of FDA approved medications in different patient populations.